News

Published on 11 Mar 2024 on Zacks via Yahoo Finance

How Much Upside is Left in Replimune Group, Inc. (REPL)? Wall Street Analysts Think 50.17%


Article preview image

Shares of Replimune Group, Inc. (REPL) have gained 16.4% over the past four weeks to close the last trading session at $9.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.56 indicates a potential upside of 50.2%.

The mean estimate comprises nine short-term price targets with a standard deviation of $2.60. While the lowest estimate of $10 indicates a 10.7% increase from the current price level, the most optimistic analyst expects the stock to surge 110.4% to reach $19. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

NASDAQ.REPL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings

Overview of the Recent Transaction On September 30, 2024, Morgan Stanley executed a significant t...

GuruFocus.com ยท via Yahoo Finance 8 Oct 2024

How Much Upside is Left in Replimune Group, Inc. (REPL)? Wall Street Analysts Think 50.17%

Shares of Replimune Group, Inc. (REPL) have gained 16.4% over the past four weeks to close the la...

Zacks via Yahoo Finance 11 Mar 2024

What Makes Replimune Group, Inc. (REPL) a New Buy Stock

Replimune Group, Inc. (REPL) could be a solid choice for investors given its recent upgrade to a ...

Zacks via Yahoo Finance 8 Mar 2024

Wall Street Analysts See a 70.57% Upside in Replimune Group, Inc. (REPL): Can the Stock Really Move...

Shares of Replimune Group, Inc. (REPL) have gained 0.8% over the past four weeks to close the las...

Zacks via Yahoo Finance 23 Feb 2024

Replimune Group Inc (REPL) Reports Fiscal Q3 2024 Results and Extends Cash Runway

<img src=https://s.yimg.com/ny/api/res/1.2/GFFacjMQE5JFxUpwjOKI8A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyM...

GuruFocus.com via Yahoo Finance 8 Feb 2024

An Intrinsic Calculation For Replimune Group, Inc. (NASDAQ:REPL) Suggests It's 24% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Replimune Group fair value estimate is U...

Simply Wall St. via Yahoo Finance 7 Dec 2023

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22% By Investing.com

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22%

Investing.com 6 Dec 2023

Crude Oil Moves Lower; AutoZone Profit Tops Views - AutoZone (NYSE:AZO), Clearmind Medicine...

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher on T...

Benzinga 6 Dec 2023

US Stocks Down; JM Smucker Posts Upbeat Earnings - Designer Brands (NYSE:DBI), Allarity Therapeutics...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 50 points on Tuesda...

Benzinga 5 Dec 2023

Insider Sell: Pamela Esposito Sells 5,658 Shares of Replimune Group Inc

On September 12, 2023, Pamela Esposito, the Chief Business Officer of Replimune Group Inc (NASDAQ...

GuruFocus.com via Yahoo Finance 15 Sep 2023